Background:
Intravascular ultrasound (IVUS) has been utilized to
determine acute stent mal-apposition (ASM) after percutaneous coronary
intervention (PCI) in the left main coronary artery (LMCA). However, the clinical
consequences of this finding remain uncertain. This research aimed to evaluate
the clinical implications of ASM in the LMCA using IVUS.
Methods:
In
this study, 408 patients who underwent successful drug-eluting stent (DES)
implantation in the LMCA were evaluated. We analyzed the prevalence and
characteristics of ASM and its correlation with clinical outcomes. ASM is
characterized by stent struts that are not in immediate proximity to the intimal
surface of the vessel wall after initial stent deployment.
Results:
The observed incidence of LMCA-ASM post-successful PCI was
26.2%, both per patient and per lesion. Lesions with LMCA-ASM had a longer stent
diameter, larger stent areas, and larger lumen areas compared to those without
LMCA-ASM (4.0
0.5
vs
. 3.7
0.4 mm,
p
0.001;
9.8
2.0
vs
. 9.0
1.6
,
p
0.001; 12.3
1.9
vs
. 10.1
2.1
,
p
0.001,
respectively). The mean external elastic membrane (EEM) area (odds ratio (OR):
1.418 [95% confidence interval (CI): 1.295–1.556];
p
0.001) emerged as an independent predictor of LMCA-ASM. During the
observation period, LMCA-ASM did not display any association with device-oriented
clinical endpoints (DoCE), which included cardiac death, target vessel-induced
myocardial infarction (MI), stent thrombosis, and target lesion revascularization
(TLR). Moreover, the DoCE incidence exhibited no significant disparity between
patients with or without ASM (13.1
vs
. 6.0%,
p
= 0.103).
Conclusions:
While LMCA-ASM was a not uncommon finding post-PCI, it did
not correlate with adverse cardiac events in the present study.